Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02500862 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Characterization of Potential Biomarkers of Eye Disease and Vision

Study acronym: EYE-MARKER
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v16
  2. Trial status: Active, Not Recruiting to Recruiting
    • Primary completion date: Dec 2019 to Dec 2026
    • Study completion date: Jun 2023 to Dec 2026
    • Site details revised
    v15
  3. Study completion date: Apr 2023 to Jun 2023v14
  4. Study completion date: Feb 2023 to Apr 2023v13
  5. Study completion date: Dec 2022 to Feb 2023v12
Show 10 earlier versionsHide 10 earlier versions
  1. Study completion date: Dec 2021 to Dec 2022v11
  2. Study completion date: Jan 2021 to Dec 2021v10
  3. Study completion date: Apr 2020 to Jan 2021v9
  4. Study completion date: Dec 2019 to Apr 2020v8
  5. Primary completion date: Dec 2017 to Dec 2019
    • Study completion date: Dec 2018 to Dec 2019
    v7
  6. Study completion date: Dec 2017 to Dec 2018
    • Site details revised
    v6
  7. Primary and study completion dates: Dec 2016 to Dec 2017v5
  8. Primary and study completion dates: Feb 2016 to Dec 2016
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v4
  9. Re-verified, no change to tracked fieldsv3
  10. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Jul 2015 to Sep 2015
    • Study sites: 0 to 1
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Characterize potential biomarkers of sight-threatening eye diseases based on the information acquired in clinical practice at CEC, AIBILI
Trial Details
NCT Number NCT02500862
Lead Sponsor Association for Innovation and Biomedical Research on Light and Image
Conditions
(from sponsor)		 Eye Disease
Related terms Eye Diseases
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov